Photo taken from Mass General Cancer Center/X
Aug 28, 2024, 05:03
Individualized cancer therapy boosts immune activity – Mass General Cancer Center
Mass General Cancer Center shared a post on X:
“A study led by researchers at Mass General Cancer Center found that an individualized cancer therapy tailored to the unique tumor profiles of patients with melanoma and lung cancer was well-tolerated and boosted immune activity.”
Individualized Cancer Therapy Demonstrates Safety and Sustained Immune Responses published in Massachusetts General Hospital.
